In laboratory experiments, UC San Francisco researchers successfully beat back the growth of aggressive liver cancers using a surprising new approach. Traditionally, targeted cancer therapies aim to disable proteins borne of cancer-driving genes. Instead, the UCSF scientists prevented these proteins, including those that shield tumors ...

Using a divide and conquer strategy, researchers from the University of California San Francisco have provided a road map for the development of a precision medicine approach to osteosarcoma, the most common bone cancer in children and young adults and an aggressive disease for ...

The amount of radiation that patients are exposed to from computed tomography (CT) scans varies widely between institutions and countries, and is largely due to differences in the technical settings of the scanning machines at each institution, according to an international study led by ...

A landmark mammography study has found that women who receive annual breast cancer screenings will have a lower mortality rate and will benefit more from therapy upon diagnosis of breast cancer. The lead investigator on this study was László Tabár, MD. He and his ...

In the year since announcing an ambitious, $5 billion fundraising campaign, UC San Francisco has seen record-breaking generosity from its supporters, inspired by faculty-led ideas to tackle some of the toughest problems in health and science. See More of UCSF’s 2018 Year in Review » ...

Black men in the United States are known to suffer disproportionately from prostate cancer. Now, a new study investigating prostate cancer deaths by race has found that African American men have twice the chance of dying from low-risk prostate cancer than men of other racial ...